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The human gut is colonized by an enormous amount of microorganisms, the so called 
microbiota. The microbiota degrades dietary components in the colon and utilize 
them as substrates in their metabolism. Dietary fibres are the most important energy 
source for the microbiota. Some dietary fibres are classified as prebiotics, as they 
have the ability to alter the composition and activity of the microbiota and promote 
health benefits. 
 Cereals are the major source of dietary fibres in Scandinavia. Among the cereals, 
rye (Secale cereale) and oat (Avena sativa) are most frequently consumed as whole 
grains. The aim of this literature study was to review the current knowledge about the 
prebiotic properties of arabinoxylan and β-Glucan, the major dietary fibres in rye and 
oats.  
 A prebiotic substrate is selective and confer health benefits. The result shows that 
arabinoxylan and β-Glucan fermentation display prebiotic properties. Both confer 
health benefits by indirectly stimulating beneficial metabolite production of the short-
chain fatty acids acetate, propionate and butyrate. The literature shows that arabi-
noxylan particularly promotes butyrate production, while β-Glucan promotes propi-
onate production and in some conditions butyrate as well.  
 Butyrate has been shown to improve intestinal integrity, prevent inflammation 
and exhibit an anti-carcinogenic effect. Propionate inhibits cholesterol synthesis. 
However, health effects of dietary fibres can depend on the individual responsiveness 
to a substrate, the so-called enterotype. In general, a diet with various dietary fibres 
has been connected to health benefits, partly because it prevents production of detri-
mental metabolites that is formed in the absence of fermentable carbohydrates. 
 Future studies will have to further confirm the prebiotic properties of arabinoxy-
lan and β-Glucan in vivo with human subjects. If such studies would present enough 
scientific support for authority health claims, it may be a way to increase the con-
sumption of dietary fibres in the population and contribute to improving public 
health. 
 
Keywords: Cereals, dietary fibres, prebiotics, arabinoxylan, β-Glucan, short-chain 
fatty acids  
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Människans mag-tarmkanal är koloniserad av ett enormt antal mikroorganismer, den 
så kallade mikrobiotan. I tjocktarmen bryter mikrobiotan ner komponenter i maten 
och använder dem som substrat i sin metabolism. Kostfibrer är mikrobiotans viktig-
aste energikälla. Vissa kostfibrer klassas som prebiotika, eftersom de har förmågan 
att påverka kompositionen och aktiviteten hos mikrobiotan och ge positiva hälsoef-
fekter. 
 Cerealier är den största kostfiberkällan i Skandinavien, och av dem är det råg 
(Secale cereale) och havre (Avena sativa) som oftast konsumeras som fullkorn. Syftet 
med denna litteraturstudie var attsammanställa den nuvarande kunskapen om de 
prebiotiska egenskaperna hos kostfibrerna arabinoxylan och β-Glukan, som finns i 
högst mängd i råg och havre.  
 Prebiotiska substrat är selektiva och ger hälsofördelar. Resultatet visar att fermen-
teringen av arabinoxylan och β-Glukan har prebiotiska egenskaper. Båda ger hälso-
fördelar genom att indirekt stimulera gynnsam metabolitproduktion av de kortkedjiga 
fettsyrorna acetat, propionat och butyrat. Litteraturen visar att arabinoxylan särskilt 
gynnar butyratproduktion, medan β-Glukan gynnar propionatproduktion och under 
visa förhållanden även butyrat. 
  Butyrat har visats förbättra tarmbarriärens integritet, motverka inflammation och 
ha en anti-carcinogen effekt. Propionat inhiberar kolesterolsyntes. Men hälsoeffekter 
av kostfibrer kan även bero på individens mottaglighet för ett substrat, den så kallade 
enterotypen. Generellt har en varierad kost med många olika kostfibrer kopplats till 
bättre hälsa, vilket delvis beror på en minskning av skadliga metaboliter som kan 
produceras i tjocktarmen när det är brist på fermenterbara kolhydrater.  
 Framtida studier bör vidare bekräfta den prebiotiska effekten av arabinoxylan och 
β-Glukan in vivo. Om sådana studier skulle visa på tillräckligt vetenskapligt stöd för 
att utfärda hälsopåståenden, kan det vara ett sätt att öka kostfiberkonsumtionen I po-
pulationen och bidra till att förbättra folkhälsan. 
 
 
Nyckelord: Cerealier, kostfibrer, prebiotika, arabinoxylan, β-Glukan, kortkedjiga 
fettsyror 
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AXOS Arabinoxylo-oligosaccharides 
GI Gastrointestinal 
SCFAs Short-chain fatty acids 
XOS Xylo-oligosaccharides 
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The human gut is colonized by an enormous amount of inhabitants - the so called 
microbiota. In the past few years the microbiota and its proclaimed impact on hu-
man health has become a hot topic in the Western society. The microbiota consists 
of over 1014 microbes, which is more than the number of cells in the human body. 
While the microbe community is called the ‘microbiota’ their common collection 
of genes goes under the name ‘microbiome’ (Clemente et al., 2012).  
 The human existence is highly dependent on the symbiosis with the microbiota. 
The continuous host-microbiota interactions are part of a complex ecosystem, 
sometimes referred to as ‘the forgotten organ’, because of its extensive metabolic 
activity and essential role in the function of the human body (O’Hara & Shanahan, 
2006). The microbiota composition is influenced by both internal and external fac-
tors, e.g. genetics, age, antibiotic usage and stress. One of the most influential fac-
tors is what the microbiota is fed with on a daily basis – the diet. The microbes use 
the dietary food components as substrates in their energy metabolism (Holscher, 
2017). 
 The carbohydrate polymers that resist intestinal degradation, the dietary fibres, 
are important substrates for the microbiota (Holscher, 2017). The interaction be-
tween dietary fibres and the microbiota has gained more interest, as the concept of 
‘prebiotics’ emerged about 20 years ago (Gibson et al., 2017). Prebiotics are die-
tary fibres that have the ability to alter microbiota composition and activity 
(Holscher, 2017). Metabolites, mainly short-chain fatty acids (SCFAs), are the 
end-products of the microbial degradation and has been observed to have benefi-
cial physiological effects (Knudsen & Erik, 2015) 
 Cereal dietary fibres are less mentioned in connection to the prebiotic concept. 
Although they have been shown to possess prebiotic properties they are not gener-
ally accepted as prebiotics (Kellow et al., 2014). However, the functionality of ce-
real dietary fibres compared to well-established prebiotics, e.g. inulin and fruc-
tooligosaccharides, have been emphasized in the literature (Karppinen et al., 2000; 
Rose, 2014). Especially since those prebiotics often origin from less commonly 
consumed foods. 
1 Introduction 
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 Cereals are the major source of dietary fibres in Scandinavia (Andersson et al., 
2014) and the highest content of dietary fibres is found in whole-grain products 
(Egervärn et al. 2018). Rye (Secale cereale) and oat (Avena sativa) are the cereals 
most frequently consumed as whole grains (Welch, 2011; Andersson et al., 2014). 
Rye in the form of whole-grain bread (Knudsen & Lærke, 2014) and oats mostly 
in the form of breakfast cereals (Welch, 2011). The major dietary fibres in rye and 
oat are arabinoxylan and β-Glucan, respectively. Both are known to influence gas-
trointestinal health (Carlson et al., 2018). 
 The Western population consume less dietary fibres than recommended – the 
so called ‘fiber gap’ (Requena et al., 2018). The recommended intake of fibre to 
maintain colonic health is 25 to 35g/day for adults, but the average intake in the 
Swedish population is 20g/day (Amcoff et al., 2012).  
 Dietary fibre consumption within the population have important implications 
for public health. The purpose of this thesis is to review the knowledge about the 
prebiotic properties of cereal dietary fibres. It is a highly relevant topic considering 
its potential to point out more advantages of whole grain consumption and play a 
role in future diet recommendations. 
1.1 Aim 
The aim of this thesis is to review the current knowledge about the prebiotic prop-
erties of arabinoxylan and β-Glucan, as they are the major dietary fibres in rye and 
oat. The question to be answered is: How are arabinoxylan and β-Glucan metabo-
lised by the human microbiota and can the fermentation end-products in extension 
affect human health? 
 In order to answer this question, the composition of dietary fibres, the diet-mi-
crobiota interactions and the definition of prebiotic properties will be described. 
The discussion on the impact on human health will be limited to production of 
short-chain fatty acids and their health effects. Other aspects of prebiotics, e.g. 
diet-induced shifts in the microbiota composition, is beyond the scope of this the-
sis and will not be considered. 
1.2 Method 
Information for this literature study was mainly scientific articles found by search-
ing in the data bases Google Scholar, Web of Science, Scopus and PubMed. The 
following words were used in different combinations to make the literature search: 
microbiota, gut, prebiotic*, ”dietary fibre*”, ”dietary fiber*”, *, cereal*, rye, 
oat*, arabinoxylan, β-Glucan*, enterotype*, ”short-chain fatty acid*”, SCFA*, 
butyrate, health. 
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 Since the research field of prebiotics is relatively new, the literature that has 
been used is dominated by publications from the last 10 years. Books providing an 
overview of the nutritional aspects of rye and oats were also used in addition to the 
scientific articles.  
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2.1 The human microbiota 
Koropatkin et al. (2012) describes the importance of the co-evolved symbiosis be-
tween the human genome and the microbiome. Humans would only be able to de-
grade a few carbohydrate polymers, e.g. starch, lactose and sucrose, without mi-
crobial assistance in addition to the endogenous enzymes. Many plant polysaccha-
rides are far more complex and contain a range of glycoside linkages, each requir-
ing specific degrading enzymes that the inhabitants of the microbiota provide.  
 The microbiota contains both ‘generalists’ and ‘specialists’, which target differ-
ent glycoside linkages (Koropatkin et al., 2012). The phylum Bacteroidetes are 
generalists and Firmicutes are specialists, but they cooperate through cross-feed-
ing. Bacteroidetes degrade the primary substrates and Firmicutes subsequently uti-
lize their end-products (Requena et al., 2018). 
2.2 Microbial diversity 
The broad taxonomic groups of the microbiota are quite stable through a lifetime. 
However, a proportion of the microbiota is constantly shifting in numbers depend-
ing on external factors, e.g. short-term changes of the composition have been ob-
served within 24 hours after dietary interventions (Koropatkin et al., 2012).  
 The dietary changes following industrialization in the Western population have 
resulted in a decreased diversity of the microbiota over time, which has been con-
nected to a higher prevalence of e.g. metabolic diseases, inflammatory bowel dis-
ease and colon cancer (Requena et al., 2018).  
 Egervärn et al. (2018) from the Swedish National Food Agency states that a 
diet rich in dietary fibres, together with a low intake of animal-derived fats and 
proteins, is related to increased microbial diversity and health benefits. That is evi-
2 Prebiotics 
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dent in studies of populations eating plenty of dietary fibres, e.g. a small popula-
tion in Amazonas was found to have the most species-rich microbiota so far inves-
tigated. 
2.3  Definition of prebiotics 
The concept of ‘prebiotics’ emerged in 1995 to describe fermentable carbohy-
drates, mainly fructooligosaccharides (FOS), inulin and galactooligosaccharides 
(GOS), that modulated microbiota composition. These compounds had been seen 
to promote growth of e.g. Lactobacillus and Bifidobacterium spp., which are con-
sidered beneficial for human health (Gibson & Roberfroid, 1995). 
 There are different opinions about the meaning and correct usage of the term 
‘prebiotics’. Delcour et al. (2016) argue that the most well-established prebiotics 
(inulin, FOS and GOS) should not be separated from other fermentable carbohy-
drates that also modulate microbiota composition and activity. Delcour et al. 
(2016) emphasize the importance of rather discussing the functionality of the mi-
crobiota and its fermentation patterns, than focusing on a narrow range of the mi-
crobial community. They argue that the meaning of the concept should evolve as 
knowledge about the microbiota increase. 
 Actually there is an ongoing development of the concept, as the definition was 
recently broadened and updated by an expert consensus panel from The Interna-
tional Scientific Association for Probiotics and Prebiotics. Gibson et al. (2017) 
state in the article that a prebiotic is defined as “a substrate that is selectively uti-
lized by host microorganisms conferring a health benefit”. This definition will be 
the starting point when discussing the prebiotic properties of arabinoxylan and β-
Glucan in this literature study. 
 A prebiotic must fulfil two requirements according to this definition, i.e. to be 
selective and confer health benefits. Gibson et al. (2017) define selectively as a 
substrate that target a specific range of the microbiota. In contrast to the older defi-
nitions, the selectivity is no longer solely limited to promotion of beneficial micro-
bial genera. In terms of metabolite production, a prebiotic would e.g. need to pro-
mote specific parts of the microbiota that are known producers of butyrate. A com-
pound that stimulates growth of the microbial community in general is not quali-
fied as a prebiotic. 
 Gibson et al. (2017) further describes the second requirement concerning 
health benefits, that can be fulfilled either if the substrate directly stimulates bene-
ficial microbial genera or if it indirectly stimulates beneficial metabolite produc-
tion. They also emphasize that the prebiotic effect should be confirmed in well-
controlled in vivo studies. The studies need to show causality between microbial 
activity and health benefits, e.g. modulation of the metabolite production. The total 
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microbial diversity of the community should be taken into account when evaluat-
ing the prebiotic effect, which is why in vitro systems is not considered sufficient 
(Gibson et al., 2017). 
2.4 Enterotypes 
The individual microbiota composition is a significant aspect when discussing 
how diet influence the microbiota. According to Chen et al. (2017), the microbiota 
is not homogenous within the human population and can display different fermen-
tation patterns even though the same dietary components are consumed. A classifi-
cation of the microbiome in two ‘enterotypes’ have recently emerged (Arumugam 
et al., 2011). As Requena et al. (2018) describes, the first enterotype is dominated 
by the genera Prevotella and is linked to a long-term consumption of complex car-
bohydates. Bacteroides dominates when the diet constitutes a higher proportion of 
animal fats and proteins, as is usually the case in industrialized populations.  
 The implication for the metabolite production, as decribed by Chen et al. 
(2017), is that the same substrate may give rise to different SCFA profiles depend-
ing on the enterotype. Thus, possible health effects of dietary fibres are not only 
dependent on the substrate supply, but also the individual responsiveness to the 
substrate. It has been suggested that customized dietary strategies to promote 
health will emerge in the future, as the knowledge about the enterotypes increase 
(Chen et al., 2017; Kovatcheva-Datchary et al., 2015). 
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3.1 Definition 
The definition of dietary fibre was traditionally based solely on chemical proper-
ties, but have more recently evolved to include more physiologic aspects (Carlson 
et al., 2018). The European Union regulation (EU) No 1169/2011 defines dietary 
fibre as ”carbohydrate polymers with three or more monomeric units, which are 
neither digested nor absorbed in the human small intestine”. The carbohydrate pol-
ymers are either consumed in raw form in food, modified from natural carbohy-
drate sources or synthetically produced. The two latter are also required  to “have a 
beneficial physiological effect demonstrated by generally accepted scientific evi-
dence” to be classified as dietary fibres. 
3.2 Sources and properties 
Dietary fibres are a diverse group of carbohydrates originating from the plant 
kingdom, consumed in the human diet in the form of cereals and grains, legumes, 
nuts, fruits and vegetables. Solubility, fermentability and viscosity affect the phys-
iological effects of dietary fibres (Mudgil, 2017). Chemical properties, such as 
molecular weight, also influence the physiological effect (Rakha et al., 2010). 
 Dietary fibres are most commonly classified by their solubility, according to 
Mudgil (2017). The soluble dietary fibres are either viscous or non-viscous. The 
main soluble dietary fibre in cereals are β-Glucan. The majority of the cereal grain 
cell-walls consists of insoluble fibres (Mudgil, 2017), that are mostly located in 
the outer layers of the kernel (Daou Cheickna & Zhang Hui, 2012) and are further 
divided into celluloses, which are totally insoluble, and hemicelluloses, which are 
partially soluble (Coultate, 2015). A major insoluble fibre in whole grain cereals is 
the hemicellulose arabinoxylan (Mudgil, 2017). However, both soluble and insolu-
ble arabinoxylans are found in rye (Knudsen & Erik, 2015). 
3 Dietary fibres 
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 Insoluble fibres have a substantial bulk effect due their hydrophilic molecular 
structure that can bind water and increase faecal mass. The bulking also has the fa-
vourable effect of diluting potential toxic metabolites in the colon content and 
limit their contact with the epithelial cells (Mudgil, 2017). 
3.3 Gastrointestinal degradation 
Microbial fermentation of dietary components occurs in the colon, the final part of 
the gastrointestinal tract (GI) (Koropatkin et al., 2012). Several studies have 
shown that there are regional differences in the microbiota composition and fer-
mentation pattern along the GI tract. The microbial population gradually increase 
from a limited number of species in the small intestine, to a very dense and diverse 
community in the distal colon (Koropatkin et al., 2012). Fermentation of soluble 
fibres, such as β-Glucan, occurs in the proximal colon where microbial activity is 
high (Knudsen & Erik, 2015). Fermentation of insoluble fibres occurs in the distal 
parts of the colon, where the fermentation rate and transit time is slower (Koropat-
kin et al., 2012). 
 The microbial degradation process is affected by the molecular structure of the 
dietary fibre as well as the complexity of the plant material, e.g. cell wall polysac-
charides may be folded in a matrix structure (Koropatkin et al., 2012) that delays 
substrate availability (Mudgil, 2017). Food processing, e.g. cooking and milling, 
also affect substrate availability and affect the fermentation process (Koropatkin et 
al., 2012). 
 Fermentation of dietary fibres results in SCFA production and a decrease of the 
colonic pH. The SCFA concentration varies along the GI tract (Hamer et al., 
2008). It is highest in the proximal colon and decreases subsequently. The pH fol-
lows the opposite pattern with the lowest pH being found in the proximal colon 
(Glitsø et al., 1998). The mean pH of the proximal and distal colon is approxi-
mately 5.6 and 6.3, respectively (Hamer et al., 2008). 
3.4 Dietary fibres in cereals 
3.4.1 Composition 
Nonstarch polysaccharides, mainly arabinoxylans, β-Glucan and cellulose, to-
gether with resistant starch, fructans and lignin constitutes the dietary fibres in ce-
reals. Most dietary fibres are found in the outer tissues, which means that the con-
sumed amount will depend on how the grain has been processed (Knudsen & Erik, 
2015).  
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 The composition (Table 1) varies among rye, wheat, oat and barley. It should 
be noted that the content differs greatly between measurements and the values 
listed here are only one example. Rye have a higher content of arabinoxylan than 
any of the other cereals. It also contains most dietary fibres in total, between 13-
17% according to Rakha et al. (2010). Oats have a significantly smaller content of 
dietary fibre, between 6-9%, but a high content of soluble fibres in the form of β-
Glucan (Daou Cheickna & Zhang Hui, 2012).  
Table 1. Dietary fibre content in cereals on g/100g dry-matter basis. 
Dietary fibrea Rye Wheat Oat Barley 
Total, excl. fructans 13.0 10.6 7.7 11.7 
Fructan 2.4-3.1 1.5-2.0 0.6-1.0 0.6-1.0 
Soluble DF 4.5 2.3 4.5 3.9 
Insoluble DF 8.5 8.3 3.2 7.8 
Cellulose 1.3 1.7 0.6 1.4 
Other insoluble 7.2 6.5 2.6 6.4 
β-Glucan 2.1 0.83 4.4 4.2 
Arabinoxylanb 6.5-12.0 5.8-6.5 2.0-4.5 4.0-7.0 
a Numbers are for whole-grain rye, wheat, oat-meal and pearled barley and derived from Welch 
(2011) for all dietary fibres except arabinoxylan. b Numbers from Rose (2014). 
3.4.2 Arabinoxylan 
Arabinoxylan is a type of xylan, which is the major group of hemicellulose found 
in cereal grains (Coultate, 2015). The highest content of arabinoxylan is found in 
rye, where it contributes to more than half of the dietary fibres. The molecule, 
showed in Figure 1, is based on a linear xylose backbone with β1→4 linkages and 
arabinose side chains (Kellow & Walker, 2018). The arabinose substituents are 
linked at one of the O-2 and O-3 positions or at both of them (Andersson et al., 
2014). 
 Phenolic compounds can also be linked to the xylose backbone (Kellow & 
Walker, 2018). Ferulic acid is the most common phenolic substituent in the arabi-
noxylan structure found in rye. Ferulic acid has the ability to form cross-linkages, 
which highly influence the viscosity and solubility properties of the molecule (An-
dersson et al., 2014).  
 Arabinoxylans are found in a range of molecular weights and substitution pat-
terns. The A/X ratio describes the proportion of arabinose substituents in relation 
to the xylose backbone. Arabinoxylans in different parts of e.g. the rye kernel have 
different A/X ratios, which influence the physiochemical properties of the tissues 
(Andersson et al., 2014). The A/X ratio is closely related to solubility and explains 
why arabinoxylans exist in both soluble and insoluble forms. A high A/X ratio, i.e. 
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many arabinose side chains in relation to the xylose units, increase the solubility 
(Kellow & Walker, 2018). 
 
 
 
Figure 1. Molecular structure of arabinoxylan. 
3.4.3 β-Glucan 
The major soluble dietary fibre of cereals is the linear (1→3)(1→4)-β-D-glucan, 
the short name used is β-Glucan. The structure of the molecule is shown in Figure 
2. The molecule is highly soluble because of the (1→3) link, that makes the mole-
cule less tightly packed than e.g. cellulose (Andersson et al., 2014). β-Glucan oc-
curs in the highest concentrations in oats and barley (Welch, 2011).  
 Most of the β-Glucan in oats are located in the walls of the endosperm, the sub-
aleurone layer. The viscosity of β-Glucan has been widely examined in relation to 
the health-promoting properties of oats. β-Glucan has a well-established effect of 
lowering serum cholesterol (Daou Cheickna & Zhang Hui, 2012), which has been 
recognized in health claims stated by both U.S. Food and Drug Administration and 
EFSA (Cloetens et al., 2012).  
 The viscosity of β-Glucan increases exponentially with molecular weight (Mä-
lkki & Virtanen, 2001). The viscosity has been found to be lower in barley than in 
oats, which may be related to the lower molecular weight found in barley (Cloe-
tens et al., 2012). The chemical properties determine the physiological activity and 
should be considered when discussing health effects (El Khoury et al., 2012). 
16 
 
 
 
Figure 2. Molecular structure of β-Glucan. 
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4.1 Fermentation products  
Acetate, propionate and butyrate are the main end-products of microbial fermenta-
tion in the gut (Koh et al., 2016). Besides the dietary substrates, endogenous mate-
rial of the colon also acts as substrates for fermentation, e.g. glycoproteins and ex-
foliated epithelial cells (Knudsen et al., 2003). 
 The SCFAs are formed by different microbial species and reaction pathways. 
Acetate is produced with pyruvate as the building block, by most species of the 
microbiota and constitutes the largest portion of the SCFAs (Koh et al., 2016). 
 A smaller range of the microbiota produce propionate and butyrate (Knudsen & 
Erik, 2015). Propionate is produced mainly by Bacteroides spp. (Koh et al., 2016), 
with the assistance of several Firmicutes that supply vitamin B12 as a cofactor (Re-
quena et al., 2018). Butyrate is produced with either acetate or lactate as substrate 
(Koh et al., 2016). The most prevalent butyrate-producing species of the human 
microbiota belong to the Firmicutes phylum (Requena et al., 2018).  
 Different substrates give rise to different concentrations of total SCFAs as well 
as ratios of acetate, propionate and butyrate. The concentration of SCFAs is meas-
ured in the faeces, which is a representational model of the actual fermentation oc-
curring in the colon (Valeur et al., 2016). 
  
4.1.1 Absorption of SCFAs 
The SCFAs, mainly butyrate, act as the primary energy source for the epithelial 
cells of the colon that metabolise them through beta-oxidation (Knudsen et al., 
2003). Over 95% of the butyrate is immediately metabolized by the epithelial cells 
(Hamer et al., 2008) and the rest is metabolized in the liver along with propionate. 
4 Fermentation and metabolite production 
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Acetate is the SCFA found in highest concentration in the peripheral circulation 
since it is not as readily metabolized (Koh et al., 2016), although small concentra-
tions of propionate and butyrate is also found (Morrison & Preston, 2016). 
 The SCFAs influence pH, bioavailability of minerals and inhibition of patho-
genic bacteria (Gullón et al., 2014) as well as acting as signalling molecules be-
tween the microbiota and the host. They can bind to peripheral receptors and influ-
ence functions in other parts of the body, besides acting as an energy source for 
the epithelial cells (Morrison & Preston, 2016).  
 
       
 
Figure 3. Acetate, propionate and butyrate. 
4.2 Arabinoxylan fermentation 
4.2.1 Degradation process 
The microbial degradation of arabinoxylan involves several enzymatic steps. It oc-
curs along a wider range of the colon length compared to e.g. the oligosaccharides, 
that are more readily fermented in the proximal colon (Salden et al., 2018). Once 
arabinoxylan enters the colon it is first degraded by Roseburia and Bacteroides 
spp. that produce endoxylanase enzymes (Broekaert et al., 2011). The enzymes 
hydrolyse the polymer into the shorter arabinoxylo-oligosaccharides (AXOS) and 
xylo-oligosaccharides (XOS) chains. These are further degraded to their constitut-
ing arabinose and xylose units by the enzymes arabinofuranosidase and xylanase, 
that are formed by Bifidobacterium spp. among others. About 15% of the con-
sumed arabinoxylan is never degraded but will instead contribute to faecal bulk 
and reduced transit time (Kellow & Walker, 2018). 
4.2.2 Fermentation profile 
In the recent review by Knudsen & Erik (2015) they conclude that the fermenta-
tion of arabinoxylan results in an increased total SCFA production. It has been ob-
served as a result of arabinoxylan, AXOS and XOS fermentation in animal studies 
(Broekaert et al., 2011). It was also observed to increase in human intervention 
studies (Hald et al., 2016) together with a faecal pH reduction (Salden et al., 
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2018). The pH reduction favours the abundance of beneficial saccharolytic spe-
cies, e.g. Bacteroides, Roseburia and Lactobacillus, which has been observed both 
in vitro and in vivo (Kellow & Walker, 2018). 
 Although there is less evidence for the prebiotic properties of arabinoxylan 
compared to e.g. inulin and FOS, it has been argued that all the requirements for a 
full prebiotic status is fulfilled (Broekaert et al., 2011). One example of such an ar-
gument is an in vitro study that showed a higher SCFA production from wheat-de-
rived AXOS than fermentation of FOS, which is considered the ‘golden standard’ 
of prebiotics (Gullón et al., 2014). 
4.2.3 Butyrate production 
The in vitro studies of the SCFA ratio have shown some contradicting results, but 
most human in vivo studies indicate that arabinoxylan particularly favours produc-
tion of butyrate (Knudsen & Erik, 2015). 
 Both butyrate and acetate production increased when arabinoxylan consump-
tion was compared to a low-fibre Western diet (Hald et al., 2016). Though, as 
Knudsen & Erik (2015) mentions, some animal studies did not result in a higher 
butyrate ratio. They suggest that the butyrate production depends on the food ma-
trix. Arabinoxylan in whole-grain foods are more slowly fermented and decrease 
pH in a wider length of the colon, which may favour the proportion of butyrate in 
the SCFA ratio.  
4.2.4 Physiological effects 
Several studies have been performed recently of wheat-derived arabinoxylan and 
AXOS and their potential link to beneficial health effects in humans. Although, 
further human in vivo studies will be necessary to establish causal effects.  
 AXOS was shown to have a preventive effect against obesity and metabolic 
disorders in obese mice fed with a western diet (Neyrinck et al., 2018). High mo-
lecular weight arabinoxylan has been shown to influence the gut barrier and im-
mune system in vitro and in animal studies. On the contrary, when the effect of a 
6-week arabinoxylan treatment to improve gut permeability was tested in a human 
intervention, it failed to show any significant results, apart from a generally in-
creased SCFA production (Salden et al., 2018).  
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4.3 β-Glucan fermentation 
4.3.1 Fermentation profile 
β-Glucan is more rapidly fermented than arabinoxylan (Karppinen et al., 2000) 
and can be 100% fermented, since its chemical structure makes it readily degraded 
by the microbiota. The major products of the fermentation are acetate, propionate 
and butyrate (Drzikova et al., 2005). An increased total SCFA concentration has 
been observed for β-Glucan in oat bran compared to rye bra, wheat bran and inulin 
(Karppinen et al., 2000). 
 Knudsen & Erik (2015) mentions that the molecular weight of β-Glucan influ-
ences the fermentation profile. Low molecular weight β-Glucan appears to pro-
duce a higher total SCFA concentration and lower pH than high molecular weight 
β-Glucan (Dong et al., 2017). In animal studies, a higher ratio of propionate and 
butyrate to acetate has been observed with increasing molecular weight (Immer-
strand et al., 2010).  
4.3.2 Propionate production 
Several studies have shown that β-Glucan has a propionate-rich fermentation pro-
file compared to FOS and inulin (Nordlund et al., 2012) as well as pectin and re-
sistant starch (James L. Casterline et al., 1997). In vitro faecal fermentations have 
also acknowledged that β-Glucan produces a high proportion of propionate 
(Hughes et al., 2008; Carlson et al., 2017).  
4.3.3 Butyrate production 
The literature is not consistent regarding the butyrate production of β-Glucan fer-
mentation. The fermentation profile for thick and thin oat flakes tested in an in 
vitro system, was considered to be abundant in propionate but also showed an in-
creased proportion of butyrate in the thicker flakes (Connolly et al., 2010). Mice 
fed with a diet based on oat flour and oat bran showed a higher butyrate produc-
tion in the caecum compared to the control group (Drzikova et al., 2005). Knudsen 
& Erik (2015) also points to several in vivo studies that show enhanced faecal 
butyrate formation as a result of β-Glucan fermentations. 
 Whole-grain oats seem to provide a more butyrate-rich profile than fermenta-
tion of β-Glucan alone. The butyrate enhancement has been suggested to origin 
from the high content of resistant starch found in some oat-based products (Rose, 
2014). This corresponds to the previously mentioned suggestion that the SCFA 
profile is highly dependent on the food matrix (Knudsen & Erik, 2015) 
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 Only a few in vivo studies on humans relating β-Glucan consumption to metab-
olite production were found in the literature. In a 3-month oat bran intervention in 
ulcerative colitis patients, the faecal butyrate concentration increased after 4 weeks 
(Nie et al., 2017). Another 3-month intervention with β-Glucan bread showed an 
increased butyrate ratio after 1 month, compared to the placebo group, which 
thereafter declined (Turunen et al., 2011). However, no significant increase in total 
SCFA concentration was observed in a 1-week study, when oat-meal porridge was 
consumed by 10 human subjects (Valeur et al., 2016). These studies are relevant if 
there is an aim to establish β-Glucan as a prebiotic, more human in vivo studies are 
needed. 
 
 
22 
 
5.1 Fermentation patterns 
Hamer et al. (2008) describes that saccharolytic fermentation is preferred by the 
microbiota, since carbohydrates are most often their preferred energy source. Fer-
mentation of proteins, proteolytic fermentation, dominates when fermentable car-
bohydrates are not available. The produced proteolytic metabolites, e.g. branch-
chained fatty acids, ammonia and amines, are considered unfavourable for host 
health. These metabolites have been linked to several GI diseases that are usually 
more prevalent in the distal colon. According to Hamer et al. (2008), it correlates 
to the fact that proteolytic fermentation is more likely to occur in the distal colon if 
the supply of fermentable dietary fibres is low. Dietary fibre consumption has been 
observed to decrease the proteolytic metabolite concentration, e.g. in a dietary in-
tervention with arabinoxylan and resistant starch (Hald et al., 2016). 
 A versatile plant-based diet offers the microbiota a diverse collection of dietary 
fibres with various physiochemical properties. Such a diet provides substrates 
along a broader region of the colon and promotes a more diverse fermentation pro-
file by the microbiota (Holscher, 2017). The conventional diet in industrialized 
populations contains a small variety of dietary fibres and does not promote a bene-
ficial fermentation pattern (Requena et al., 2018).  
5.2 Metabolic effects 
The SCFAs act on peripheral tissues and may impact insulin sensitivity and glu-
cose homeostasis (Knudsen & Erik, 2015). Morrison & Preston (2016) describes 
that the circulating SCFAs, dominated by acetate but also smaller amounts of pro-
pionate and butyrate, induce differentiation of fat cells making them smaller in 
size. Acetate also inhibits the breakdown of lipids into free fatty acids in the adi-
pose tissue, which have implications for glucose homeostasis. Morrison & Preston 
5 Health effects 
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(2016) as well as Koh et al. (2016) mention that acetate may influence appetite 
regulation, by stimulating the hormone leptin or by acting on hypothalamus. Propi-
onate also exhibit metabolic effects, e.g. by modifying lipid metabolism in the 
liver, as animal studies have shown an inhibitory effect on cholesterol synthesis 
(Kellow et al., 2014). 
5.3 Immune function 
Butyrate regulates tight junction proteins and is involved in improving the integ-
rity of the intestinal barrier. Increased permeability of the barrier is connected to 
intestinal inflammation, which in turn has been linked to obesity and insulin re-
sistance (Morrison & Preston, 2016). A few clinical trials have been performed to 
the test the anti-inflammatory effect of butyrate in treatment of GI inflammatory 
diseases. Some mechanisms behind this effect have been suggested, but further 
studies are required to confirm this relationship (Hamer et al., 2008). 
5.4 Colon cancer 
Epidemiological studies have shown a correlation between dietary fibre consump-
tion and decreased incidence of colon cancer. It has been suggested that butyrate 
concentration in the colon might play a role in this correlation (Hamer et al., 
2008).  
 Butyrate act inhibitory on colon cancer in animal studies and in vitro, but hu-
man intervention studies are still lacking. Addition of butyrate to cancerous cells 
in vitro induce an anti-carcinogenic effect. It is thought that butyrate inhibits the 
enzyme histone deacetylase (HDAC), subsequently altering the expression of 
genes involved in cell proliferation and apoptosis (Hamer et al., 2008). Propionate 
has also been seen to have a smaller but similar effect (Koh et al., 2016).  
 Cancerous cells and noncancerous cells respond differently to butyrate, a phe-
nomenon called ‘the butyrate paradox’ (Hamer et al., 2008). Proliferation of non-
cancerous cells is not inhibited by butyrate and in some studies, on the contrary, it 
has been observed to be stimulated by butyrate (Donohoe et al., 2012). The mech-
anisms of butyrate as a signalling molecule in this interaction is still uncertain 
(Koh et al., 2016).  
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Dietary fibres have many positive health benefits, one of them is the production of 
favourable metabolites in the colon. The result of this literature study shows that 
both arabinoxylan and β-Glucan fermentation display prebiotic properties. They 
are selective by influencing microbial activity of limited parts of the microbiota. 
Arabinoxylan seems to particularly promote parts of the microbiota that produce 
butyrate and β-Glucan especially promotes propionate production. The effect of β-
Glucan on butyrate production is inconsistent and seems to depend on the food 
matrix as well as molecular weight. Both arabinoxylan and β-Glucan increase the 
production of SCFAs, which indirectly confers health benefits, since the SCFAs 
are involved in interactions that promote health. 
 The understanding of the diet-microbiota-health interactions is still in its in-
fancy. The Swedish National Food Agency recently published a report about the 
current knowledge in the area, concluding that there are connections indeed, but 
the mechanisms are still unknown (Egervärn et al. 2018). This report further en-
hances the notion that prebiotics are of particular interest and there are strong rea-
sons to focus on this field of research. 
 In conclusion, there is much potential in broadening the prebiotic concept with 
a higher emphasis on the functionality of foods that commonly occur in the West-
ern diet. Future studies will have to confirm the prebiotic properties of arabinoxy-
lan and β-Glucan in controlled in vivo studies of human subjects. Preferably future 
studies will also focus on the enterotypes and their responsiveness to arabinoxylan 
and β-Glucan interventions. If such studies would present enough scientific sup-
port for authority health claims, it may be a way to overbridge the ‘fiber gap’ and 
improve public health. 
6 Discussion 
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